These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome. Reddy MM; Chinoy P; Grieco MH J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880 [TBL] [Abstract][Full Text] [Related]
12. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. Fox RI; Theofilopoulos AN; Altman A J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome. Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935 [TBL] [Abstract][Full Text] [Related]
14. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans. Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674 [TBL] [Abstract][Full Text] [Related]
16. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation. Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915 [TBL] [Abstract][Full Text] [Related]
17. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102 [TBL] [Abstract][Full Text] [Related]
18. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Friedman J; Schattner A; Shvidel L; Berrebi A Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153 [TBL] [Abstract][Full Text] [Related]
19. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity. Takeda A; Minato N; Kano S Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects. Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]